Penumbra, Inc Payments to Acquire Equity Method Investments
Penumbra, Inc (PEN) reported Payments to Acquire Equity Method Investments of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireEquityMethodInvestments · last filed 2026-02-25
- Penumbra, Inc payments to acquire equity method investments for the quarter ending 2019-12-31 was $0.00.
- Penumbra, Inc payments to acquire equity method investments for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- Penumbra, Inc payments to acquire equity method investments for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
- Penumbra, Inc payments to acquire equity method investments for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- Penumbra, Inc payments to acquire equity method investments for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Penumbra, Inc payments to acquire equity method investments for fiscal 2024 was $10.00M.
- Penumbra, Inc payments to acquire equity method investments for fiscal 2023 was $0.00.
- Penumbra, Inc payments to acquire equity method investments for fiscal 2022 was $0.00.
| Period end | Payments to Acquire Equity Method Investments 3 month | Payments to Acquire Equity Method Investments 6 month | Payments to Acquire Equity Method Investments 9 month | Payments to Acquire Equity Method Investments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-25 | |||
| 2024-12-31 | $10.00M 10-K · filed 2026-02-25 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-25 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-18 | |||
| 2020-12-31 | $0.00 10-K · filed 2021-02-23 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $0.00 derived: sum of 2 quarters · filed 2021-02-23 | $0.00 derived: sum of 3 quarters · filed 2021-02-23 | $0.00 10-K · filed 2021-02-23 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | $0.00 derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $0.00 10-Q · filed 2019-08-06 | $0.00 derived: sum of 3 quarters · filed 2021-02-23 | $514.00K derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-07 | $0.00 derived: sum of 2 quarters · filed 2021-02-23 | $514.00K derived: sum of 3 quarters · filed 2021-02-23 | $1.03M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $514.00K derived: sum of 2 quarters · filed 2021-02-23 | $1.03M derived: sum of 3 quarters · filed 2021-02-23 | $1.38M 10-K · filed 2021-02-23 |
| 2018-09-30 | $514.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.03M derived: sum of 2 quarters · filed 2019-11-07 | $1.38M 10-Q · filed 2019-11-07 | $1.52M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $516.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $868.00K 10-Q · filed 2019-08-06 | $1.00M derived: sum of 3 quarters · filed 2020-02-26 | $1.06M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $352.00K 10-Q · filed 2019-05-07 | $487.00K derived: sum of 2 quarters · filed 2020-02-26 | $543.00K derived: sum of 3 quarters · filed 2020-02-26 | $5.62M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $135.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $191.00K derived: sum of 2 quarters · filed 2020-02-26 | $5.26M derived: sum of 3 quarters · filed 2020-02-26 | $5.26M 10-K · filed 2020-02-26 |
| 2017-09-30 | $56.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $5.13M derived: sum of 2 quarters · filed 2018-11-05 | $5.13M 10-Q · filed 2018-11-05 | $5.13M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $5.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $5.07M 10-Q · filed 2018-08-07 | $5.07M derived: sum of 3 quarters · filed 2019-02-26 | $5.07M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-08 | $0.00 derived: sum of 2 quarters · filed 2019-02-26 | $0.00 derived: sum of 3 quarters · filed 2019-02-26 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $0.00 derived: sum of 2 quarters · filed 2019-02-26 | $0.00 10-K · filed 2019-02-26 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-08 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |